Dr. David Murray, MD

NPI: 1083733513
Total Payments
$2,308
2023 Payments
$47.36
Companies
7
Transactions
11

Payment Breakdown by Category

Travel$1,225 (53.1%)
Other$890.39 (38.6%)
Food & Beverage$192.83 (8.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $1,225 5 53.1%
Grant $890.39 2 38.6%
Food and Beverage $192.83 4 8.4%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $927.08 2 $0 (2019)
AbbVie, Inc. $864.08 1 $0 (2017)
Millennium Pharmaceuticals, Inc. $164.18 1 $0 (2017)
GENZYME CORPORATION $141.31 3 $0 (2023)
Celgene Corporation $115.00 2 $0 (2018)
AstraZeneca Pharmaceuticals LP $75.78 1 $0 (2017)
Legend Biotech USA Inc. $21.05 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $47.36 2 GENZYME CORPORATION ($26.31)
2019 $63.00 1 E.R. Squibb & Sons, L.L.C. ($63.00)
2018 $230.00 4 Celgene Corporation ($115.00)
2017 $1,968 4 AbbVie, Inc. ($864.08)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
06/08/2023 Legend Biotech USA Inc. Food and Beverage In-kind items and services $21.05 General
06/06/2023 GENZYME CORPORATION Grant Cash or cash equivalent $26.31 General
06/12/2019 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $63.00 General
06/09/2018 Celgene Corporation Travel and Lodging Cash or cash equivalent $67.00 General
06/09/2018 GENZYME CORPORATION NO PRODUCT DISCUSSED (Drug) Travel and Lodging Cash or cash equivalent $67.00 General
06/09/2018 Celgene Corporation Food and Beverage Cash or cash equivalent $48.00 General
06/09/2018 GENZYME CORPORATION NO PRODUCT DISCUSSED (Drug) Food and Beverage Cash or cash equivalent $48.00 General
10/08/2017 AstraZeneca Pharmaceuticals LP TAGRISSO (Drug) Food and Beverage In-kind items and services $75.78 General
Category: Oncology
06/30/2017 AbbVie, Inc. Grant Cash or cash equivalent $864.08 General
06/30/2017 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $864.08 General
06/30/2017 Millennium Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $164.18 General

About Dr. David Murray, MD

Dr. David Murray, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083733513.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Murray, MD has received a total of $2,308 in payments from pharmaceutical and medical device companies, with $47.36 received in 2023. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($1,225).

Practice Information

  • Specialty Anatomic Pathology & Clinical Pathology
  • Other Specialties Cytopathology, Clinical Pathology/Laboratory Medicine
  • Location Rochester, MN
  • Active Since 03/28/2007
  • Last Updated 10/06/2020
  • Taxonomy Code 207ZP0102X
  • Entity Type Individual
  • NPI Number 1083733513

Products in Payments

  • NO PRODUCT DISCUSSED (Drug) $115.00
  • TAGRISSO (Drug) $75.78

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in Rochester